Compare MSTR & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSTR | TEVA |
|---|---|---|
| Founded | 1989 | 1901 |
| Country | United States | Israel |
| Employees | N/A | 32842 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.6B | 39.2B |
| IPO Year | 1998 | N/A |
| Metric | MSTR | TEVA |
|---|---|---|
| Price | $110.02 | $32.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 8 |
| Target Price | ★ $343.77 | $38.63 |
| AVG Volume (30 Days) | ★ 18.3M | 5.4M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $463,456,000.00 | N/A |
| Revenue This Year | $5.22 | N/A |
| Revenue Next Year | $2.41 | $2.97 |
| P/E Ratio | ★ N/A | $28.19 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $105.00 | $14.99 |
| 52 Week High | $457.22 | $37.35 |
| Indicator | MSTR | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 32.42 | 41.95 |
| Support Level | $105.00 | $30.53 |
| Resistance Level | $192.21 | $32.74 |
| Average True Range (ATR) | 8.98 | 1.17 |
| MACD | -1.36 | -0.30 |
| Stochastic Oscillator | 0.60 | 31.12 |
Strategy Inc is a bitcoin treasury company and a provider of business intelligence services. It is designed to provide investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed-income instruments. The company also provides industry AI-powered enterprise analytics software. It has one reportable operating segment: the Software Business, which is engaged in the design, development, marketing, and sales of the company's enterprise analytics software platform through cloud subscriptions and licensing arrangements and related services (i.e., product support, consulting, and education). Geographically, the company operates in EMEA, U.S. and Other Regions, of which maximum revenue is derived from U.S..
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.